Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.
Miltefosine (MFS) is an alkylphosphocholine used for the local treatment of cutaneous metastases of breast cancer and oral therapy of visceral leishmaniasis. Recently, the drug was reported in in vitro and preclinical studies to exert significant activity against different developmental stages of sc...
Main Authors: | Maha M Eissa, Riham M El-Moslemany, Alyaa A Ramadan, Eglal I Amer, Mervat Z El-Azzouni, Labiba K El-Khordagui |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4648507?pdf=render |
Similar Items
-
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
by: Maha M. Eissa, et al.
Published: (2020-09-01) -
Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
by: Amara RO, et al.
Published: (2018-08-01) -
Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.
by: Marwa H El-Faham, et al.
Published: (2017-08-01) -
Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits
by: Lubna M. Eldesouky, et al.
Published: (2021-03-01) -
Bioactivity of miltefosine against aquatic stages of <it>Schistosoma mansoni, Schistosoma haematobium </it>and their snail hosts, supported by scanning electron microscopy
by: El Bardicy Samia, et al.
Published: (2011-05-01)